A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Clinical trial NCT05140811 · UNKNOWN
Trial details
- NCT number
- NCT05140811
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2024-02-05
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.